We are live on ! Find out more
Pathstone Holdings

Pathstone Holdings Portfolio holdings

AUM $34.3B
1-Year Est. Return 27.35%
This Fund
S&P 500
This Quarter Est. Return
+16.84%
1 Year Est. Return
+27.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$34.3B
AUM Growth
+$9.2B
Cap. Flow
+$5.75B
Cap. Flow %
16.75%
Top 10 Hldgs %
30.68%
Holding
2,429
New
207
Increased
1,120
Reduced
878
Closed
99

Sector Composition

Rank Sector Weight
1 Miscellaneous 56.92%
2 Technology 14.03%
3 Financials 6.88%
4 Consumer Discretionary 4.13%
5 Industrials 4.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPE icon
451
Hewlett Packard
HPE
$69B
$8.83M 0.03%
195,012
+20,734
+12% +$749K
DB icon
452
Deutsche Bank
DB
$77.7B
$8.77M 0.03%
259,776
+48,638
+23% +$1.58M
DFAE icon
453
Dimensional Emerging Core Equity Market ETF
DFAE
$10.2B
$8.73M 0.03%
217,043
+16,551
+8% +$640K
WST icon
454
West Pharmaceutical
WST
$23.9B
$8.7M 0.03%
24,202
+606
+3% +$185K
IJS icon
455
iShares S&P Small-Cap 600 Value ETF
IJS
$8.29B
$8.69M 0.03%
63,600
-5,724
-8% -$738K
EWJ icon
456
iShares MSCI Japan ETF
EWJ
$23.3B
$8.69M 0.03%
93,153
+5,173
+6% +$470K
VXF icon
457
Vanguard Extended Market ETF
VXF
$31.3B
$8.68M 0.03%
35,237
+1,317
+4% +$302K
HCA icon
458
HCA Healthcare
HCA
$87.7B
$8.67M 0.03%
22,146
+1,447
+7% +$612K
SLYG icon
459
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5B
$8.67M 0.03%
72,747
+821
+1% +$88.8K
REGN icon
460
Regeneron Pharmaceuticals
REGN
$85.2B
$8.65M 0.03%
13,825
-2,087
-13% -$1.42M
FCX icon
461
Freeport-McMoran
FCX
$104B
$8.58M 0.03%
135,894
+10,389
+8% +$668K
NKE icon
462
Nike
NKE
$57B
$8.58M 0.03%
207,804
+40,958
+25% +$1.8M
WSM icon
463
Williams-Sonoma
WSM
$26.8B
$8.57M 0.03%
36,763
+49
+0.1% +$9.71K
HAL icon
464
Halliburton
HAL
$30.9B
$8.55M 0.02%
251,737
-410
-0.2% -$16K
SNPS icon
465
Synopsys
SNPS
$75.5B
$8.54M 0.02%
19,073
+1,212
+7% +$570K
MAA icon
466
Mid-America Apartment Communities
MAA
$14.9B
$8.52M 0.02%
62,501
+1,413
+2% +$184K
AMP icon
467
Ameriprise Financial
AMP
$49.5B
$8.51M 0.02%
18,506
-65
-0.4% -$29.8K
APD icon
468
Air Products & Chemicals
APD
$67.1B
$8.51M 0.02%
28,978
+375
+1% +$109K
CTAS icon
469
Cintas
CTAS
$80.2B
$8.5M 0.02%
49,125
+4,039
+9% +$698K
MEDP icon
470
Medpace
MEDP
$16.5B
$8.4M 0.02%
15,870
+9,255
+140% +$4.27M
ARCC icon
471
Ares Capital
ARCC
$14.4B
$8.4M 0.02%
453,206
-6,639
-1% -$124K
VTHR icon
472
Vanguard Russell 3000 ETF
VTHR
$4.83B
$8.33M 0.02%
25,149
+640
+3% +$205K
STRL icon
473
Sterling Infrastructure
STRL
$14.9B
$8.3M 0.02%
9,887
-2,356
-19% -$1.65M
SONY icon
474
Sony
SONY
$143B
$8.29M 0.02%
413,043
+76,581
+23% +$1.61M
CL icon
475
Colgate-Palmolive
CL
$70.8B
$8.28M 0.02%
90,011
-903
-1% -$79K

Similar funds

Pathstone Holdings's Q2 2026 Portfolio in Review

As of Q2 2026, Pathstone Holdings held 2,429 positions worth $34.3B, up 37% from $25.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pathstone Holdings deployed $5.75B of net new capital in Q2 2026, opening 207 new positions and adding to 1,120 existing holdings. Its largest new stake was Vanguard Total Corporate Bond ETF: 979,361 shares worth $75.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, up from 50% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was CrowdStrike, an estimated $73.7M trimmed.

  • Pathstone Holdings's largest Q2 2026 buy was Vanguard Total Corporate Bond ETF: 979,361 shares worth $75.2M.
  • Pathstone Holdings added most to Vanguard Morningstar Growth ETF in Q2 2026, an estimated $1.25B increase.
  • Pathstone Holdings's biggest Q2 2026 reduction was CrowdStrike, cutting an estimated $73.7M.
  • Pathstone Holdings fully exited Western Asset Emerging Markets Debt Fund in Q2 2026, selling an estimated $8.89M.
  • Pathstone Holdings's ten largest holdings make up 31% of its $34.3B portfolio in Q2 2026.
  • Pathstone Holdings opened 207 new positions and closed 99 in Q2 2026.
  • Pathstone Holdings's portfolio value rose 37% quarter-over-quarter to $34.3B.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.